The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the Cell Therapy Catapult’s announcement that it will build its new £55 million state-of-the-art cell therapy manufacturing centre in Stevenage.Read more
ABPI Chief Executive, Stephen Whitehead, comments on the publication of the Government’s 'Our plan for growth: science and innovation'.Read more
The Association of the British Pharmaceutical Industry (ABPI) and the Department of Health have today announced the third quarter payment from industry of £79 million to underwrite the growth of the medicines bill under the 2014 Pharmaceutical Price Regulation Scheme (PPRS). This takes the total payment made by industry in 2014 to £229 million.Read more
The Review on Antimicrobial Resistance (AMR) has today published its first paper Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations which estimates that failing to tackle drug-resistant infections will cause 10 million deaths and cost up to US $100 trillion a year by 2050.Read more
Our website is currently experiencing scrolling issues when viewed using Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version of Internet Explorer or use Chrome or Firefox.
Board of Management